The Factory Floor: Suanfarma Expands API Capacity With Sandoz Deal In Italy

Meanwhile, Glenmark, Aurobindo And Cipla Have Run-ins With The FDA.

 
• By Akriti Seth

Suanfarma acquires an API manufacturing facility in Italy to accelerate its growth in Europe, while CapsCanada relocates its headquarters as part of its growth strategy. Meanwhile, Glenmark, Aurobindo and Cipla struggle with quality issues.

Scientist_Lab
The latest growth initiatives and quality control measures in the pharma space • Source: Shutterstock

More from Manufacturing

More from Business